Dan S Suesskind - Net Worth and Insider Trading

Dan S Suesskind Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dan S Suesskind owns 1 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) .

Click here to see the complete history of Dan S Suesskind’s form 4 insider trades.

Insider Ownership Summary of Dan S Suesskind

Ticker	Company	Transaction Date	Type of Owner
TEVA	Teva Pharmaceutical Industries Ltd	2018-01-01	director

Dan S Suesskind Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dan S Suesskind Ownership Network

Ownership Network List of Dan S Suesskind

No Data

Ownership Network Relation of Dan S Suesskind

Dan S Suesskind Owned Company Details

What does Teva Pharmaceutical Industries Ltd do?

Who are the key executives at Teva Pharmaceutical Industries Ltd?

Dan S Suesskind is the director of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include Exec. VP & European Commercial Richard Daniell , President and CEO Richard D Francis , and See "Remarks" Eric A Hughes .

Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary

Over the past 18 months, Dan S Suesskind made no insider transaction in Teva Pharmaceutical Industries Ltd (TEVA). Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 475,266 shares made by Richard Daniell , a net sale of 100,893 shares made by Eric A Hughes , and a net sale of 18,012 shares made by Vikki L Conway .

In summary, during the past 3 months, insiders sold 502,741 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 502,741 shares. During the past 18 months, 2,185,838 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,185,838 shares.

Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Teva Pharmaceutical Industries Ltd Insider Transactions

No Available Data

Dan S Suesskind Mailing Address

Above is the net worth, insider trading, and ownership report for Dan S Suesskind. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dan S Suesskind's mailing address is: Petach Tikva L3 49131.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.